Bernhard Hebich

Statistics

Publications

Citations

363

H-Index

Active since

2017

Affiliations

BioNTech (Germany)(Current)

University Medical Center of the Johannes Gutenberg University Mainz

Johannes Gutenberg University Mainz

BioNTech (United States)

Helmholtz Institute Mainz

Bernhard Hebich is an author at BioNTech (Germany) specializing in bispecific antibody discovery, bispecific antibody therapy, and therapeutic monoclonal antibodies.

Publications per year

2017–2024

Publications

Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Christiane Stadler, Hayat Bähr-Mahmud, Leyla Çelik et al. · Nature Medicine · 2017 · 277 citations

Life Sciences, Molecular Biology, Oncology +12

Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6

Christiane Stadler, Ursula Ellinghaus, Leyla Fischer et al. · Science Translational Medicine · 2024 · 55 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody

Hayat Bähr-Mahmud, Ursula Ellinghaus, Christiane Stadler et al. · OncoImmunology · 2023 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16

1–3 of 3